Sleep News and Research

Latest Sleep News and Research

Fat-rich breakfast may help prevent metabolic syndrome, says study

The age-old maxim "Eat breakfast like a king, lunch like a prince and dinner like a pauper" may in fact be the best advice to follow to prevent metabolic syndrome, according to a new University of Alabama at Birmingham (UAB) study.

31 Mar 2010

Bright light therapy box for SAD, depression, bipolar disorder and sleep problems

Alaska Northern Lights manufactures a bright light therapy box that aids in treating chronic health problems such as seasonal affective disorder (SAD), depression, bipolar disorder and sleep problems. Sufferers of SAD, a form of clinical depression, include up to 25 percent of those living in northern latitudes who experience varying degrees of SAD during winter months when there is less natural light. Night shift workers are also susceptible to SAD which affects over one third of the population, or about 10.8 million Americans.

31 Mar 2010

Vantage Communications becomes agency of record for ImThera Medical

Vantage Communications, an award-winning global PR firm, today announced that it is the agency of record for ImThera Medical, Inc. Within a few months, Vantage Communications successfully promoted ImThera and its medical device technology with original coverage garnered in top-tier publications such as Neurotech Insights, ENToday, The Gray Sheet, Sleep Review, Respiratory & Sleep Management, Respiratory Therapy, Medical Device Daily, and medGadget.

31 Mar 2010

NMS Labs launches test to evaluate the efficacy of Milnacipran

NMS Labs launches another unique test suitable for the evaluation of toxicity vs. efficacy, the potential for physicians to establish therapeutic drug monitoring of individual patients, and the assessment of drug diversion of a new pain management drug therapy.

31 Mar 2010

Parents’ presence in the recovery room may reduce children’s behavior problems

All parents worry when their child is undergoing surgery and anesthesia. You might assume that children undergoing surgery would be much relieved to find Mom or Dad is there when they wake up—but that's not necessarily the case, according to a study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

31 Mar 2010

Depomed licensee submits DM-1796 NDA for management of PHN

Depomed, Inc. today announced that its licensee has submitted a New Drug Application (NDA) for DM-1796 to the U.S. Food and Drug Administration (FDA) for the management of postherpetic neuralgia (PHN), or pain after shingles. DM-1796 is an investigational, extended release, once-daily tablet formulation of gabapentin designed to reduce dosing frequency and have a low incidence of side effects.

31 Mar 2010

Top neurologists to receive 2010 AAN Alliance Awards

The American Academy of Neurology will recognize the outstanding achievements of researchers in neurology during the AAN's 62nd Annual Meeting in Toronto, April 10 through 17, 2010, the world's largest gathering of neurologists with more than 2,000 presentations on the latest advances in neurologic research.

31 Mar 2010

Racial disparity in infant sleep-related deaths

A study conducted by Children's Memorial Research Center reveals that African American infants are far more likely to die from sleep-related causes than any other ethnic group in Illinois.

30 Mar 2010

Cephalon receives FDA Complete Response Letter for NUVIGIL supplemental new drug application

Cephalon, Inc. today announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.

30 Mar 2010

FDA grants SynCardia Systems conditional approval to conduct IDE study of Freedom driver system

SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.

29 Mar 2010

American obesity problem: Ongoing support to make lifestyle and behavior changes needed

An administration task force chaired by the U.S. Departments of Agriculture, Education and Health and Human Services is asking the public for recommendations to solve the American obesity problem, and a new poll by the American Psychological Association may have some answers.

29 Mar 2010

Cortex signs agreement to sell certain AMPAKINE compounds to Biovail

Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.

29 Mar 2010

Managing Technetium-99m shortage: MedSolutions provides advisory

MedSolutions, a leading provider of medical management services, has provided an advisory for payors and providers on options regarding the shortage of Technetium-99m (Tc-99m), a radioactive tracer isotope that is widely-used in nuclear medicine studies.

27 Mar 2010

FDA Advisory Committee to review VIVUS' NDA for Qnexa

VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.

26 Mar 2010

Senate briefing to discuss TB and drug-resistant TB

A Senate briefing today will discuss TB and drug-resistant TB, including multidrug-resistant TB (MDR-TB) and extensively drug resistant (XDR-TB), the impact on global health and the current state of surveillance, diagnosis and treatment around the world.

26 Mar 2010

Work addiction is a psychosocial problem

Researchers from the Jaume I University have proven the usefulness of DUWAS, a new scale for measuring addiction to work, a disorder that affects around 12% of all working people in Spain.

26 Mar 2010

SENSIMED Triggerfish developed to diagnose and treat patients with glaucoma

STMicroelectronics, the world's leading supplier of MEMS (Micro-Electro-Mechanical Systems) devices for consumer and portable applications, has announced that it will develop and supply a wireless MEMS sensor that acts as a transducer, antenna and mechanical support for additional read-out electronics in a breakthrough platform developed by Swiss company Sensimed AG.

26 Mar 2010

New interactive Web site for veterans and military family members

Geisinger recently launched www.PAVetFamilyWeb.com. This Web site is designed to serve Pennsylvania families who are coping with military separations and multiple deployments of a service member as well as caregivers, wounded warriors, service members and military veterans.

26 Mar 2010

Arena Pharmaceuticals initiates patient screening for phase 1 clinical trial of APD916

Arena Pharmaceuticals, Inc. announced today the initiation of patient screening in a Phase 1 clinical trial of APD916, a novel oral drug candidate discovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy and cataplexy.

25 Mar 2010

Pay-For-Performance program to improve quality of patient care

The ATS has released an official policy statement of pay-for-performance (P4P) in pulmonary, critical care and sleep medicine. In the statement, the Society encourages clinicians in these fields to participate in P4P programs and views them as an opportunity to partner with healthcare payors, accrediting organizations, governmental oversight groups and others to improve quality, rather than as a threat to autonomy and independence.

25 Mar 2010